pharmacie et médicaments – Déremboursement de médicaments traitant la maladie d'Alzheimer

This written question asks the French government about its policy on the reimbursement of drugs used to treat Alzheimer's disease. It seeks clarification on decisions regarding the delisting of certain Alzheimer's medications and their potential impact on patient access to treatment.